Milnda (MiRNDa, Inc.) is a Tokyo-based biotech startup developing RNA-modification analysis technology for early cancer detection, building on research from Japan Cabinet Office SIP program. The company aims to bring a Japan-originated cancer screening test to global markets, targeting hard-to-detect cancers such as pancreatic and liver cancer.
1
Round
1
Industry
4
Tags
Aug 28, 2026
Latest raise
Funding activity · 1 round
Aug 28, 2026
JPY -1
Seed
Led by Global Brain Corporation
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
